Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | LIVN | TRMD |
|---|---|---|
| Price | $76.43 | $41.05 |
| Change today | ▲ 1.81% | ▲ 2.63% |
| Market cap | $4.21B | $4.20B |
| Return, 3 months | -8.6% | – |
| Return, year to date | +24.2% | – |
| Return, 1 year | +45.2% | – |
| P/E (TTM) | 22.5 | 6.8 |
| P/B | 3.2 | 1.6 |
| P/E percentile vs own 5y | – | 73rd |
| Dividend yield | – | 5.90% |
| Revenue growth (YoY, latest qtr) | +10.8% | – |
| Net profit growth (YoY) | +299.7% | – |
| Gross margin | 70.1% | – |
| Operating margin | 12.7% | – |
| Net margin | 27.8% | – |
| Return on equity | – | – |
| Analyst target vs. price | +19.7% | -7.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 44 | – |
| 30-day volatility | 22.2% | – |
| Max drawdown, 1 year | -18.9% | – |
| Trend read | Leaning bearish | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
